CTOs on the Move

MiraVista Behavioral Health Center

www.miravistabhc.care

 
MiraVista is a new behavioral health treatment center opening April 2021 in the former Providence Hospital in Holyoke, MA. The newly renovated center will initially provide adult psychiatric and addiction treatment and will expand capacity to include child and adolescent services by the end of the year. Our mission is to provide compassionate, effective, sustainable care for those suffering from psychiatric distress and substance abuse. We are committed to helping fill the critical need for quality behavioral care in the Pioneer Valley and are excited to open our doors this Spring.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Evio

Evio is a pharmacy solutions startup that works with health plans to transform the medication experience for everyone: patients, providers, and the system at large.

HealthKeeperz

HealthKeeperz is an integrated health system delivering community based care for the people of North Carolina. They provide home health care, medical equipment, hospice services, and much more.

Kryptiq Corporation

Kryptiq is the leading provider of interoperability and workflow connectivity solutions for healthcare.

GoMeyra

An all-in-one fully customizable cloud-based laboratory management solution helping you manage ordering, accessioning, billing, reporting, and inventory management all with a user-friendly employer/provider portal. GoMeyra LIMS is transforming the testing industry with a system that supports operations with greater accessibility, functionality and interconnectivity. Giving labs the power to process test results with faster speeds and efficiency. Labs are able to triple capacity for same-day and give patients direct results in revolutionary times. Patients who test negative will be able to return to work and travel within 24 hours, compared to the 3-7 day quarantined wait period.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.